SCHEMBL7974466

SCHEMBL7974466

Cc1ccc(Cn2cnc3nc(-c4cccc(F)c4)[nH]c(=O)c32)cc1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.43
ALDH1A1 P00352 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
ACP1 P24666 1/20 0.43
KMT2A Q03164 2/20 0.42
GRIN1 Q05586 2/20 0.40
GRIN2B Q13224 2/20 0.40
GAA P10253 2/20 0.39
MGAM O43451 1/20 0.39
SI P14410 1/20 0.39
MGAM2 Q2M2H8 1/20 0.39
MEN1 O00255 1/20 0.39
KDM4E B2RXH2 1/20 0.38
LMNA P02545 1/20 0.38
CYP11B1 P15538 1/20 0.38
CYP11B2 P19099 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7988732 0.93 ALDH1A1 (0.45) HPGDALDH1A1SMN1; SMN2ACP1KMT2A
SCHEMBL7988952 0.91 GRIN1 (0.43) HPGDALDH1A1SMN1; SMN2ACP1KMT2A
SCHEMBL7987251 0.91 SMN1; SMN2 (0.53) HPGDALDH1A1SMN1; SMN2ACP1KMT2A
SCHEMBL7991667 0.89 ALDH1A1 (0.46) HPGDALDH1A1SMN1; SMN2ACP1KMT2A
SCHEMBL7992261 0.89 TNKS (0.43) HPGDALDH1A1SMN1; SMN2ACP1KMT2A
SCHEMBL7984419 0.89 SMN1; SMN2 (0.44) HPGDALDH1A1SMN1; SMN2ACP1KMT2A
SCHEMBL7991594 0.89 HPGD (0.44) HPGDALDH1A1SMN1; SMN2ACP1KMT2A
SCHEMBL7985561 0.88 HPGD (0.46) HPGDALDH1A1SMN1; SMN2ACP1KMT2A
SCHEMBL7985164 0.87 KMT2A (0.46) HPGDALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL7984716 0.87 SMN1; SMN2 (0.53) HPGDALDH1A1SMN1; SMN2KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed